Allan ThoenDirector & Associate General Counsel at SandozSpeaker
Agenda Sessions
Biosimilars and Generics in 2026: Market Access and Profitability Strategies
, 11:30amView Session
Biosimilars and Generics in 2026: Market Access and Profitability Strategies